JIU ' an medical treatment by large shareholders to reduce the company said no impact

China Securities Network (reporter Langzhen) September 23 Night, nine health (002432, shares bar) issued a notice, the company September 23 received the controlling shareholder Shihezi three and the Equity Investment Partnership (limited Partnership) (hereinafter referred to as "three and the company") reduction of shares of the circular, From July 24, 2013 to September 23, 2013, through the Shenzhen Stock Exchange's trading system, the company sold a total of 3.72 million shares of its unlimited sales conditions, accounting for 1% of the company's total equity.　　After the reduction, three and the company holds 173.7 million shares of the company, accounting for 46.69% of the company's total equity, still belong to the company's controlling shareholders. Back to check the announcement, the reduction notice is four months in the third time. Data show that June 28 this year, nine health care issued a notice that three and the company to reduce its holdings of 7 million shares in the company's total share capital 1.88%; July 22, nine health care again issued a bulletin said three and the company again reduce the company's unlimited sales conditions circulation shares 7.534 million shares, accounting for the company's total capital of 2.03 %, if the announcement of 23rd, three and the company has been reduced by nine health care 4.91% of the shares.　　However, three and the company also pledged to six months in a row through the securities trading system to sell the shares will not exceed the total number of shares in the company 5%.　　Nine health related person in charge of the Chinese securities Network interview, said that the holding shareholder's reduction is due to its own consideration, not to the company's development without confidence, otherwise, will not promise six months to reduce the reduction of less than 5%.　　A person who does not want to be named for the China Securities Network reporter Analysis, three and the company is an equity investment company, now coincides with nine health care listing three years to ban, as long as it is not a large-scale reduction and impact on the company, its a certain proportion of reduction, profit is also normal. In the first half of this year, nine health care to the market has launched a mobile internet body weight meter, a mobile internet blood glucose meter, a mobile internet blood oxygen instrument, a wearable health smart wrist watch. At present in the hardware, ihealth products in blood pressure, blood sugar, weight, blood oxygen, sports and other fields have reached nearly 10, the product more and more complete and diverse.　　The above-mentioned products have been FDA, CE and other related certification. But its products released, the stock price did not rise, the industry analysis is mainly due to "wearable equipment" in the short term can not give the company to form a real profit support, the company's main business is mainly composed of electronic sphygmomanometer. The first half of this year, the company's electronic sphygmomanometer operating income of 169 million yuan, accounting for about 81% of its operating income. However, nine health care sphygmomanometer, blood glucose meter and other products have been a rapid expansion of the stage, easy to increase the situation of increasing the benefits.